Related references
Note: Only part of the references are listed.Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Brief Report: Incidence of Selected Opportunistic Infections Among Children With Juvenile Idiopathic Arthritis
Timothy Beukelman et al.
ARTHRITIS AND RHEUMATISM (2013)
The risk of contracting pediatric inflammatory bowel disease in children with celiac disease, epilepsy, juvenile arthritis and type I diabetes - a nationwide study
Lauri J. Virta et al.
JOURNAL OF CROHNS & COLITIS (2013)
Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis
N. E. Aikawa et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2013)
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011
D. E. Furst et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
Timothy Beukelman et al.
ARTHRITIS AND RHEUMATISM (2012)
Progressive Multifocal Leukoencephalopathy Associated With Immunosuppressive Therapy in Rheumatic Diseases
Eamonn S. Molloy et al.
ARTHRITIS AND RHEUMATISM (2012)
Rates of Malignancy Associated With Juvenile Idiopathic Arthritis and Its Treatment
Timothy Beukelman et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
Tomoyuki Imagawa et al.
CLINICAL RHEUMATOLOGY (2012)
Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study
I. A. Ketelslegers et al.
JOURNAL OF NEUROLOGY (2012)
Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
Tomoyuki Imagawa et al.
MODERN RHEUMATOLOGY (2012)
Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab
Toshihiko Shinoki et al.
MODERN RHEUMATOLOGY (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO
Kirsten Minden et al.
RHEUMATOLOGY (2012)
A 5-year prospective population-based study of juvenile chronic arthritis: onset, disease process, and outcome
L. Bertilsson et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis
Laura Dell'Era et al.
VACCINE (2012)
Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry
A. Klein et al.
ARTHRITIS CARE & RESEARCH (2012)
2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2012)
Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists
Gulen Hatemi et al.
ARTHRITIS RESEARCH & THERAPY (2012)
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
M. W. Heijstek et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial
Pirjo Tynjala et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
David B. Clifford et al.
ARCHIVES OF NEUROLOGY (2011)
Anakinra as First-Line Disease-Modifying Therapy in Systemic Juvenile Idiopathic Arthritis Report of Forty-Six Patients From an International Multicenter Series
Peter A. Nigrovic et al.
ARTHRITIS AND RHEUMATISM (2011)
Performance of tuberculin skin test and interferon gamma assay for the diagnosis of latent tuberculosis infection in juvenile idiopathic arthritis
Secil Arslansoyu Camlar et al.
CLINICAL RHEUMATOLOGY (2011)
Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis
Ekaterina I. Alexeeva et al.
CLINICAL RHEUMATOLOGY (2011)
Malignancies in Juvenile Idiopathic Arthritis: A Preliminary Report
Sasha Bernatsky et al.
JOURNAL OF RHEUMATOLOGY (2011)
Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
Jessica L. Record et al.
JOURNAL OF RHEUMATOLOGY (2011)
Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept
Trudy D. van Dijken et al.
JOURNAL OF RHEUMATOLOGY (2011)
Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients
Taunton R. Southwood et al.
RHEUMATOLOGY (2011)
Report on malignancies in the German juvenile idiopathic arthritis registry
Gerd Horneff et al.
RHEUMATOLOGY (2011)
2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features
Timothy Beukelman et al.
ARTHRITIS CARE & RESEARCH (2011)
Integrated safety in tocilizumab clinical trials
Michael H. Schiff et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
Nicolino Ruperto et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Humoral Responses After Influenza Vaccination Are Severely Reduced in Patients With Rheumatoid Arthritis Treated With Rituximab
Sander van Assen et al.
ARTHRITIS AND RHEUMATISM (2010)
Risk Factors for Development of Uveitis Differ Between Girls and Boys With Juvenile Idiopathic Arthritis
R. K. Saurenmann et al.
ARTHRITIS AND RHEUMATISM (2010)
Long-Term Safety and Efficacy of Abatacept in Children With Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2010)
Juvenile Idiopathic Arthritis and Risk of Cancer A Nationwide Cohort Study
J. F. Simard et al.
ARTHRITIS AND RHEUMATISM (2010)
The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
Joost Frans Swart et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments
Laszlo Marodi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Critical Role for TNF in the Induction of Human Antigen-Specific Regulatory T Cells by Tolerogenic Dendritic Cells
Fleur S. Kleijwegt et al.
JOURNAL OF IMMUNOLOGY (2010)
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Ronald F. van Vollenhoven et al.
JOURNAL OF RHEUMATOLOGY (2010)
The safety profile of biologic therapies for juvenile idiopathic arthritis
Philip J. Hashkes et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Summary of worldwide pediatric malignancies reported after exposure to etanercept
Peter McCroskery et al.
PEDIATRIC RHEUMATOLOGY (2010)
The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis
Evangelia Farmaki et al.
VACCINE (2010)
The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review
Charlotte Louise Maria Krieckaert et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
F. H. M. Prince et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
G. Horneff et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
Zehra Kaymakcalan et al.
CLINICAL IMMUNOLOGY (2009)
Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
Norman Ilowite et al.
CLINICAL RHEUMATOLOGY (2009)
Anakinra for Systemic Juvenile Arthritis The Rocky Mountain Experience
Andrew Zeft et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
Purified Protein Derivative Response in Juvenile Idiopathic Arthritis
Evrim Kiray et al.
JOURNAL OF RHEUMATOLOGY (2009)
Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis
Gerd Horneff et al.
RHEUMATOLOGY (2009)
Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor α-expressing cells
Hiroki Mitoma et al.
ARTHRITIS AND RHEUMATISM (2008)
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2008)
The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment
Florence Kanakoudi-Tsakalidou et al.
CYTOKINE (2008)
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
Shumpei Yokota et al.
LANCET (2008)
Abatacept in children with juvenile idiopathic arthritis:: a randomised, double-blind, placebo-controlled withdrawal trial
Nicolino Ruperto et al.
LANCET (2008)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The effects of rituximab on immunocompetency in patients with autoimmune disease
R. John Looney et al.
ARTHRITIS AND RHEUMATISM (2008)
Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis
Marloes W. Heijstek et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2007)
Juvenile idiopathic arthritis
Angelo Ravelli et al.
LANCET (2007)
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
V Pascual et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis
DS Yim et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis
W Armbrust et al.
RHEUMATOLOGY (2004)
Incidence and prevalence of uveitis in Northern California - The Northern California Epidemiology of Uveitis Study
DC Gritz et al.
OPHTHALMOLOGY (2004)
Binding and functional comparisons of two types of tumor necrosis factor antagonists
B Scallon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Characterization of noncovalent complexes of recombinant human monoclonal antibody and antigen using cation exchange, size exclusion chromatography, and BIAcore
LC Santora et al.
ANALYTICAL BIOCHEMISTRY (2001)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Prospective survey of childhood inflammatory bowel disease in the British Isles
A Sawczenko et al.
LANCET (2001)
Etanercept in children with polyarticular juvenile rheumatoid arthritis.
DJ Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
